Filters

M H Gail
M H Greene

Showing results (1-10 of 204) with videos related to

Pageof 21
Sort By:
Annals of the New York Academy of Sciences|January 25, 2002
The estimation and use of absolute risk for weighing the risks and benefits of selective estrogen receptor modulators for preventing breast cancerM H Gail
Statistics in Medicine|November 15, 1996
Use of observational data, including surveillance studies, for evaluating AIDS therapiesM H Gail
Chest|December 1, 1994
A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung. LCSG Protocol 771M H Gail
Controlled Clinical Trials|June 1, 1985
Applicability of sample size calculations based on a comparison of proportions for use with the logrank testM H Gail
Mayo Clinic Proceedings|January 1, 1997
Genetics of breast cancerM H Greene
Mayo Clinic Proceedings|May 1, 1997
Genetics of cutaneous melanoma and neviM H Greene
Journal of the National Cancer Institute|March 4, 1992
Is cisplatin a human carcinogen?M H Greene
Cancer|January 12, 2000
The genetics of hereditary melanoma and nevi. 1998 updateM H Greene
Biometrics|March 1, 1981
Evaluating serial cancer marker studies in patients at risk of recurrent diseaseM H Gail
Cancer Treatment and Research|January 1, 1993
The prevention of cutaneous malignant melanoma: high-risk groups, chemoprevention, education, and screeningM H Greene
Pageof 21

Showing results (1-10 of 204) with videos related to

Sort By:
Pageof 21
Annals of the New York Academy of Sciences|January 25, 2002
The estimation and use of absolute risk for weighing the risks and benefits of selective estrogen receptor modulators for preventing breast cancerM H Gail
Statistics in Medicine|November 15, 1996
Use of observational data, including surveillance studies, for evaluating AIDS therapiesM H Gail
Chest|December 1, 1994
A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung. LCSG Protocol 771M H Gail
Controlled Clinical Trials|June 1, 1985
Applicability of sample size calculations based on a comparison of proportions for use with the logrank testM H Gail
Mayo Clinic Proceedings|January 1, 1997
Genetics of breast cancerM H Greene
Mayo Clinic Proceedings|May 1, 1997
Genetics of cutaneous melanoma and neviM H Greene
Journal of the National Cancer Institute|March 4, 1992
Is cisplatin a human carcinogen?M H Greene
Cancer|January 12, 2000
The genetics of hereditary melanoma and nevi. 1998 updateM H Greene
Biometrics|March 1, 1981
Evaluating serial cancer marker studies in patients at risk of recurrent diseaseM H Gail
Cancer Treatment and Research|January 1, 1993
The prevention of cutaneous malignant melanoma: high-risk groups, chemoprevention, education, and screeningM H Greene
Pageof 21
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us